Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 38 of 147 for:    visilizumab

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03524261
Recruitment Status : Recruiting
First Posted : May 14, 2018
Last Update Posted : September 12, 2019
Sponsor:
Collaborator:
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Information provided by (Responsible Party):
Fuda Cancer Hospital, Guangzhou

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 5, 2021
Estimated Study Completion Date : April 5, 2021